MaxCyte, Inc. (MXCT) stock
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3064% below fair value
$1.25+0.08 (+6.84%)
Close on Nov 18, 2026Market cap $129.01MP/E –Yield –
MaxCyte free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
MaxCyte's free cash flow for the twelve months ending Jun 30, 2026 was -$23.64M. For fiscal 2025 it was -$36.18M. The highest annual figure on record is -$10.07M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.18M | – |
| FY2024 | Dec 31, 2024 | -$29.26M | – |
| FY2023 | Dec 31, 2023 | -$25.39M | – |
| FY2022 | Dec 31, 2022 | -$33.26M | – |
| FY2021 | Dec 31, 2021 | -$14.51M | – |
| FY2020 | Dec 31, 2020 | -$10.85M | – |
| FY2019 | Dec 31, 2019 | -$10.07M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.72M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.97M | -12172.7% |
| Q3 FY2024 | Sep 30, 2024 | -$4.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.13M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.37M | – |
| Q4 FY2023 | Dec 31, 2023 | $66.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.61M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.28M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.69M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.08M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.35M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.95M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.49M | – |
See a number that looks wrong?